UniProt ID | MSX2_HUMAN | |
---|---|---|
UniProt AC | P35548 | |
Protein Name | Homeobox protein MSX-2 | |
Gene Name | MSX2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 267 | |
Subcellular Localization | Nucleus. | |
Protein Description | Acts as a transcriptional regulator in bone development. Represses the ALPL promoter activity and antogonizes the stimulatory effect of DLX5 on ALPL expression during osteoblast differentiation. Probable morphogenetic role. May play a role in limb-pattern formation. In osteoblasts, suppresses transcription driven by the osteocalcin FGF response element (OCFRE). Binds to the homeodomain-response element of the ALPL promoter.. | |
Protein Sequence | MASPSKGNDLFSPDEEGPAVVAGPGPGPGGAEGAAEERRVKVSSLPFSVEALMSDKKPPKEASPLPAESASAGATLRPLLLSGHGAREAHSPGPLVKPFETASVKSENSEDGAAWMQEPGRYSPPPRHMSPTTCTLRKHKTNRKPRTPFTTSQLLALERKFRQKQYLSIAERAEFSSSLNLTETQVKIWFQNRRAKAKRLQEAELEKLKMAAKPMLPSSFSLPFPISSPLQAASIYGASYPFHRPVLPIPPVGLYATPVGYGMYHLS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Phosphorylation | -----MASPSKGNDL -----CCCCCCCCCC | 28.54 | 25849741 | |
5 | Phosphorylation | ---MASPSKGNDLFS ---CCCCCCCCCCCC | 51.18 | 25849741 | |
12 | Phosphorylation | SKGNDLFSPDEEGPA CCCCCCCCCCCCCCE | 38.44 | 25841592 | |
43 | Phosphorylation | EERRVKVSSLPFSVE HHHCEEECCCCCCHH | 22.05 | 29083192 | |
44 | Phosphorylation | ERRVKVSSLPFSVEA HHCEEECCCCCCHHH | 42.95 | 29083192 | |
48 | Phosphorylation | KVSSLPFSVEALMSD EECCCCCCHHHHHCC | 19.67 | 29083192 | |
54 | Phosphorylation | FSVEALMSDKKPPKE CCHHHHHCCCCCCCC | 47.32 | 29083192 | |
63 | Phosphorylation | KKPPKEASPLPAESA CCCCCCCCCCCHHHH | 28.23 | 25849741 | |
91 | Phosphorylation | HGAREAHSPGPLVKP CCCCCCCCCCCCCCC | 38.30 | 30278072 | |
122 | Phosphorylation | WMQEPGRYSPPPRHM HHCCCCCCCCCCCCC | 31.29 | 28985074 | |
123 | Phosphorylation | MQEPGRYSPPPRHMS HCCCCCCCCCCCCCC | 29.57 | 25849741 | |
130 | Phosphorylation | SPPPRHMSPTTCTLR CCCCCCCCCCCCCCC | 16.99 | 24719451 | |
135 | Phosphorylation | HMSPTTCTLRKHKTN CCCCCCCCCCCCCCC | 27.75 | 22633971 | |
141 | Phosphorylation | CTLRKHKTNRKPRTP CCCCCCCCCCCCCCC | 39.72 | 22633971 | |
160 | Acetylation | QLLALERKFRQKQYL HHHHHHHHHHHHHHH | 35.21 | 24469431 | |
164 | Acetylation | LERKFRQKQYLSIAE HHHHHHHHHHHHHHH | 36.33 | 24469439 | |
207 | Ubiquitination | LQEAELEKLKMAAKP HHHHHHHHHHHHHCC | 67.06 | 22817900 | |
209 | Ubiquitination | EAELEKLKMAAKPML HHHHHHHHHHHCCCC | 37.25 | 22817900 | |
218 | Phosphorylation | AAKPMLPSSFSLPFP HHCCCCCCCCCCCCC | 39.80 | 25002506 | |
219 | Phosphorylation | AKPMLPSSFSLPFPI HCCCCCCCCCCCCCC | 19.54 | 25002506 | |
221 | Phosphorylation | PMLPSSFSLPFPISS CCCCCCCCCCCCCCC | 36.76 | 25002506 | |
227 | Phosphorylation | FSLPFPISSPLQAAS CCCCCCCCCCCHHHH | 26.58 | 25002506 | |
228 | Phosphorylation | SLPFPISSPLQAASI CCCCCCCCCCHHHHH | 30.28 | 25002506 | |
234 | Phosphorylation | SSPLQAASIYGASYP CCCCHHHHHHCCCCC | 21.25 | 25002506 | |
236 | Phosphorylation | PLQAASIYGASYPFH CCHHHHHHCCCCCCC | 12.25 | 25002506 | |
239 | Phosphorylation | AASIYGASYPFHRPV HHHHHCCCCCCCCCC | 29.04 | 25002506 | |
240 | Phosphorylation | ASIYGASYPFHRPVL HHHHCCCCCCCCCCC | 14.91 | 25002506 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MSX2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MSX2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CEBPA_HUMAN | CEBPA | physical | 12925529 | |
MSX1_HUMAN | MSX1 | physical | 9111364 | |
MSX2_HUMAN | MSX2 | physical | 9111364 | |
DLX2_HUMAN | DLX2 | physical | 9111364 | |
DLX5_HUMAN | DLX5 | physical | 9111364 | |
T2FA_HUMAN | GTF2F1 | physical | 9265625 | |
T2FB_HUMAN | GTF2F2 | physical | 9265625 | |
OBF1_HUMAN | POU2AF1 | physical | 20211142 | |
PPARG_HUMAN | PPARG | physical | 20211142 | |
TLE1_HUMAN | TLE1 | physical | 20211142 | |
TLE2_HUMAN | TLE2 | physical | 20211142 | |
ZDHC2_HUMAN | ZDHHC2 | physical | 20211142 | |
PIAS2_HUMAN | PIAS2 | physical | 9256341 | |
HBS1L_HUMAN | HBS1L | physical | 26186194 | |
ZN703_HUMAN | ZNF703 | physical | 26186194 | |
ANR40_HUMAN | ANKRD40 | physical | 28514442 | |
ZN703_HUMAN | ZNF703 | physical | 28514442 | |
HBS1L_HUMAN | HBS1L | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
168500 | Parietal foramina 1 (PFM1) | |||||
168550 | Parietal foramina with cleidocranial dysplasia (PFMCCD) | |||||
604757 | Craniosynostosis 2 (CRS2) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...